Navigating the Foreign Corrupt Practices Act for the Life Science Industry
10 December 2015
Past Event
Location
Web Conference
Partner David Simon will discuss the Foreign Corrupt Practices Act and its effect on the life sciences industry.
The webinar provides an in-depth overview of the significant risks involved when companies lack the management of compliance.
To watch a recording of the webinar, click here.
To watch a recording of the webinar, click here.
Related Services
Industry Teams
Practice Areas
Insights
Seventh Circuit Nixes Sherman Act Claims Based on the Noerr-Pennington Doctrine and Implied Antitrust Immunity
31 March 2020
Legal News: Antitrust
Utilization of Natural Phenomenon Found Patent Eligible
31 March 2020
Personalized Medicine Bulletin
COVID-19: New Law Allows Free Telehealth without Blowing Tax Benefits of Health Savings Accounts
31 March 2020
Coronavirus Resource Center
Waltz Comments on Court Ruling Allowing Inpatients to Appeal Change in Status
30 March 2020
Report on Medicare Compliance
Foley Attorneys San Diego Super Lawyers
27 March 2020
Schroeder Quoted in Law360 About Impact of Coronavirus Stimulus Package on Layoffs
27 March 2020
Law360
2020 AANP National Conference
23-28 June 2020
New Orleans, LA
gpTRAC 2020 – Telehealth Everywhere 2020 Conference
17-19 May 2020
Bloomington, MN
2020 NRTRC Conference
15-17 April 2020
WEBINAR: Responding to COVID-19 – Rapid Development and Launch Strategies for Diagnostics, Vaccines, and Therapeutics in a Global Pandemic
26 March 2020
Webinar
Navigating the Foreign Corrupt Practices Act for the Life Science Industry
Location
Web Conference